Michael J. Kamdar

Director

Michael J. Kamdar is a founder of VentiRx Pharmaceuticals, and served as Executive Vice President and Chief Business Officer until June 2011. Prior to VentiRx, Mr. Kamdar served as Senior Vice President, Corporate Development and Finance at Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) from August 2001 through June 2005. During this time, Mr. Kamdar played an instrumental role in the company's initial public offering and had responsibility for business development, finance, investor relations, corporate communications, and global strategic planning. From 2000 to 2001, Mr. Kamdar was Senior Director, Business Development at Agouron Pharmaceuticals, a Pfizer Company.

Mr. Kamdar was at Agouron from 1994 through 2001, which was acquired by Warner-Lambert in 1999. Mr. Kamdar held various business development positions and responsibilities at Agouron that culminated with his assumption of global responsibility for corporate partnering, in-licensing, technology acquisition, and strategic alliance efforts in the anti-infective, oncology, and ophthalmology therapeutic areas.

Prior to Agouron, Mr. Kamdar held various product management and new product planning positions for Hybritech, Inc., an Eli Lilly Company, and Centocor, Inc. Mr. Kamdar is a member of the Board of Directors of Tobira Therapeutics, a privately held biopharmaceutical company and BIOCOM, Southern California's life science industry organization. Mr. Kamdar received his B.S. in Biology from St. Joseph's University and his M.B.A. from Villanova University.